Olivier Loeillot is Chief Executive Officer of REPLIGEN CORP. Currently has a direct ownership of 32,556 shares of RGEN, which is worth approximately $4.64 Million. The most recent transaction as insider was on Nov 20, 2024, when has been sold 861 shares (Common Stock) at a price of $123.41 per share, resulting in proceeds of $106,256. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 32.6K
106.23% 3M change
152.25% 12M change
Total Value Held $4.64 Million

Olivier Loeillot Transaction History

Date Transaction Value Shares Traded Shares Held Form
Nov 20 2024
SELL
Payment of exercise price or tax liability
$106,256 $123.41 p/Share
861 Reduced 2.58%
32,556 Common Stock
Sep 03 2024
BUY
Grant, award, or other acquisition
-
17,631 Added 34.54%
33,417 Common Stock
Feb 27 2024
BUY
Grant, award, or other acquisition
-
2,880 Added 15.43%
15,786 Common Stock
Oct 02 2023
BUY
Grant, award, or other acquisition
-
12,906 Added 50.0%
12,906 Common Stock
OL

Olivier Loeillot

Chief Executive Officer
Waltham, MA

Track Institutional and Insider Activities on RGEN

Follow REPLIGEN CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells RGEN shares.

Notify only if

Insider Trading

Get notified when an Repligen Corp insider buys or sells RGEN shares.

Notify only if

News

Receive news related to REPLIGEN CORP

Track Activities on RGEN